Rankings
▼
Calendar
LSTA
Lisata Therapeutics, Inc.
$44M
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$7M
Gross Profit
$1M
16.8% margin
Operating Income
-$11M
-147.9% margin
Net Income
-$12M
-160.0% margin
EPS (Diluted)
$-31.32
QoQ Revenue Growth
-0.9%
Cash Flow
Operating Cash Flow
-$8M
Free Cash Flow
-$9M
Stock-Based Comp.
$851,246
Balance Sheet
Total Assets
$63M
Total Liabilities
$50M
Stockholders' Equity
$14M
Cash & Equivalents
$25M
← FY 2016
All Quarters
Q2 2016 →
LSTA Q1 2016 Earnings — Lisata Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena